Society ❯ Legal Rights ❯ Investor Rights

Class Action Lawsuits

Molina Healthcare, Inc. Bleichmar Fonti & Auld LLP Corporate Accountability LifeMD, Inc.

Cytokinetics Investors Face Nov. 17 Deadline to Seek Lead Role in Aficamten Securities Case

The pending Northern District of California lawsuit alleges the company misled investors by filing its aficamten NDA without a REMS after FDA discussions, affecting the expected review timeline.

6 ARTICLES

last mo.

James Hardie Investors Face Dec. 23 Deadline To Seek Lead Role in Securities Class Action

4 ARTICLES

2mo ago

Molina Investors Face Securities Class Action as Firms Urge Lead Plaintiff Bids by Dec. 2

3 ARTICLES

2mo ago

Class Action Lawsuits

Cytokinetics Investors Face Nov. 17 Deadline to Seek Lead Role in Aficamten Securities Case

James Hardie Investors Face Dec. 23 Deadline To Seek Lead Role in Securities Class Action

Molina Investors Face Securities Class Action as Firms Urge Lead Plaintiff Bids by Dec. 2

Molina Healthcare Hit With Investor Suit Over Medical Cost Trend Disclosures